Summary.
The specific activity and kinetic behaviour of semicarbazide-sensitive amine oxidase (EC 1.4.3.6; SSAO) towards benzylamine, in the rat heart, is affected by in vivo treatment with the non-selective monoamine oxidase (MAO) inhibitor tranylcypromine, but not by the selective MAO-A and -B inhibitors, clorgyline and lazabemide. SSAO activity was increased to 178% of control activity after 7 days of treatment with tranylcypromine. This increase appears to represent an increase in the limiting velocity (Vmax) for benzylamine oxidation with no significant change in the Km at that time-point. However, the Km for benzylamine oxidation was found to decrease in both controls and treated groups, in a time-dependent manner, during the treatment regime. These findings suggest a link between SSAO and cellular stress and may have importance in the context of the recent finding that tissue-SSAO is identical to a vascular adhesion protein (VAP1), involved in the process of inflammation.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received November 22, 2001; accepted December 21, 2001
Rights and permissions
About this article
Cite this article
Fitzgerald, D., Tipton, K. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO). J Neural Transm 109, 251–265 (2002). https://doi.org/10.1007/s007020200021
Issue Date:
DOI: https://doi.org/10.1007/s007020200021